Germany Evaluates Cold War Bunker Amid Fears of Potential Conflict With Russia
Germany is evaluating the reactivation of a Cold War nuclear bunker in Ulm as intelligence warns of potential conflict with Russia by 2029, threatening to overwhelm military hospitals with up to 1,000 daily casualties.
Germany is currently assessing the reactivation of a massive Cold War-era nuclear bunker beneath the military hospital in Ulm, built in 1979 to treat up to 2,000 people under atomic attack. With NATO intelligence warning of a potential direct conflict with Russia within years, Berlin faces grim projections of up to 1,000 casualties daily and the imminent risk of systemic collapse across its five military hospitals.
Healthcare System Under Pressure
Bloomberg reports that German authorities are rigorously auditing healthcare infrastructure to prepare for total war. Following hybrid attacks and warnings from Defense Minister Boris Pistorius that Russia could strike NATO territory by 2029, Germany is set to become the primary logistical hub for wounded soldiers.
According to a Bundeswher report, military hospitals would reach full capacity almost instantly. The mandatory integration of civilian facilities would strain the entire medical network, forcing doctors to make harrowing triage decisions between soldiers and civilians.
"Is our healthcare system ready for this? The only answer is: no. What lies ahead of us is a ruthless marathon," admitted Benedict Primert, Chief Medical Officer and commander of the Ulm military hospital.
The Race Against Time and Shortages
Beyond beds, severe personnel shortages pose a critical obstacle. Only a few hundred doctors in Germany are currently trained in battlefield trauma surgery. Intensified training courses conducted by the German Trauma Society (DGU), which utilize cadavers and anesthetized pigs, can only qualify 50 to 100 surgeons annually—a fraction of what would be required.
Furthermore, supply chain vulnerabilities compound the crisis. Critical trauma drugs take up to a year to manufacture, and European reliance on China for active pharmaceutical ingredients leaves hospitals with critically thin emergency stockpiles lasting only six weeks under current "just-in-time" delivery models.
